|
1
|
Zhang J, Gong F, Li L, Zhao M and Song J:
Diabetes mellitus and the neutrophil to lymphocyte ratio predict
overall survival in non-viral hepatocellular carcinoma treated with
transarterial chemoembolization. Oncol Lett. 7:1704–1710.
2014.PubMed/NCBI
|
|
2
|
Ozdemir Y, Akin ML, Sucullu I, Balta AZ
and Yucel E: Pretreatment neutrophil/lymphocyte ratio as a
prognostic aid in colorectal cancer. Asian Pac J Cancer Prev.
15:2647–2650. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McNamara MG, Templeton AJ, Maganti M,
Walter T, Horgan AM, McKeever L, Min T, Amir E and Knox JJ:
Neutrophil/lymphocyte ratio as a prognostic factor in biliary tract
cancer. Eur J Cancer. 50:1581–1589. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Williams KA, LabidiGaly SI, Terry KL,
Vitonis AF, Welch WR, Goodman A and Cramer DW: Prognostic
significance and predictors of the neutrophil-to-lymphocyte ratio
in ovarian cancer. Gynecol Oncol. 132:542–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Helal TE, Ibrahim EA and Alloub AI:
Immunohistochemical analysis of tumor-infiltrating lymphocytes in
breast carcinoma: Relation to prognostic variables. Indian J Pathol
Microbiol. 56:89–93. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Allard MA, Bachet JB, Beauchet A, Julie C,
Malafosse R, Penna C, Nordlinger B and Emile JF: Linear
quantification of lymphoid infiltration of the tumor margin: A
reproducible method, developed with colorectal cancer tissues, for
assessing a highly variable prognostic factor. Diagn Pathol.
7:1562012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Slootweg PJ, de Pagter M, de Weger RA and
de Wilde PC: Lymphocytes at tumor margins in patients with head and
neck cancer. Relationship with tumor size, human lymphocyte antigen
molecules, and metastasis. Int J Oral Maxillofac Surg. 23:286–289.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koshy S, Wu D, Hu X, Tajhya RB, Huq R,
Khan FS, Pennington MW, Wulff H, Yotnda P and Beeton C: Blocking
KCa3.1 channels increases tumor cell killing by a subpopulation of
human natural killer lymphocytes. PLoS One. 8:e767402013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tabbekh M, MokraniHammani M, Bismuth G and
Mami-Chouaib F: T-cell modulatory properties of CD5 and its role in
antitumor immune responses. Oncoimmunology. 2:e228412013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
el-Hag A and Clark RA: Immunosuppression
by activated human neutrophils. Dependence on the myeloperoxidase
system. J Immunol. 139:2406–2413. 1987.PubMed/NCBI
|
|
12
|
Tabuchi T, Ubukata H, Sato S, Nakata≈ I,
Goto Y, Watanabe Y, Hashimoto T, Mizuta T, Adachi M and Soma T:
Granulocytapheresis as a possible cancer treatment. Anticancer Res.
15:985–990. 1995.PubMed/NCBI
|
|
13
|
Tabuchi T, Ubukata H, Saniabadi AR and
Soma T: Granulocyte apheresis as a possible new approach in cancer
therapy: A pilot study involving two cases. Cancer Detect Prev.
23:417–421. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu H and Tabuchi T, Takemura A, Kasuga T,
Motohashi G, Hiraishi K, Katano M, Nakada I, Ubukata H and Tabuchi
T: The granulocyte/lymphocyte ratio as an independent predictor of
tumour growth, metastasis and progression: Its clinical
applications. Mol Med Rep. 1:699–704. 2008.PubMed/NCBI
|
|
15
|
Liu H, Liu G, Bao Q, et al: The baseline
ratio of neutrophils to lymphocytes is associated with patient
prognosis in rectal carcinoma. J Gastrointest Cancer. 41:116–120.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Satomi A, Murakami S, Ishida K, Mastuki M,
Hashimoto T and Sonoda M: Significance of increased neutrophils in
patients with advanced colorectal cancer. Acta Oncol. 34:69–73.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Donskov F and von der Maase H: Impact of
immune parameters on long-term survival in metastatic renal cell
carcinoma. J Clin Oncol. 24:1997–2005. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schmidt H, Suciu S, Punt CJ, et al:
American Joint Committee on Cancer Stage IV Melanoma; EORTC 18951:
Pretreatment levels of peripheral neutrophils and leukocytes as
independent predictors of overall survival in patients with
American Joint Committee on Cancer Stage IV Melanoma: Results of
the EORTC 18951 Biochemotherapy Trial. J Clin Oncol. 25:1562–1569.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Négrier S, Escudier B, Gomez F, Douillard
JY, Ravaud A, Chevreau C, Buclon M, Pérol D and Lasset C:
Prognostic factors of survival and rapid progression in 782
patients with metastatic renal carcinomas treated by cytokines: A
report from the Groupe Français d'Immunothérapie. Ann Oncol.
13:1460–1468. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Atzpodien J, Royston P, Wandert T and
Reitz M: DGCIN- German Cooperative Renal Carcinoma
Chemo-Immunotherapy Trials Group: Metastatic renal carcinoma
comprehensive prognostic system. Br J Cancer. 88:348–353. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hashimoto T, Ohno Y, Nakashima J, Gondo T,
Ohori M and Tachibana M: Clinical significance of preoperative
peripheral blood neutrophil count in patients with non-metastatic
upper urinary tract carcinoma. World J Urol. 31:953–958. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thavaramara T, Phaloprakarn C,
Tangjitgamol S and Manusirivithaya S: Role of neutrophil to
lymphocyte ratio as a prognostic indicator for epithelial ovarian
cancer. J Med Assoc Thai. 94:871–877. 2011.PubMed/NCBI
|
|
23
|
Hirashima M, Higuchi S, Sakamoto K,
Nishiyama T and Okada H: The ratio of neutrophils to lymphocytes
and the phenotypes of neutrophils in patients with early gastric
cancer. J Cancer Res Clin Oncol. 124:329–334. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suzuki S, Toyabe S, Moroda T, et al:
Circadian rhythm of leucocytes and lymphocytes subsets and its
possible correlation with the function of the autonomic nervous
system. Clin Exp Immunol. 110:500–508. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rabinowich H, Cohen R, Bruderman I,
Steiner Z and Klajman A: Functional analysis of mononuclear cells
infiltrating into tumors: Lysis of autologous human tumor cells by
cultured infiltrating lymphocytes. Cancer Res. 47:173–177.
1987.PubMed/NCBI
|
|
26
|
Kloor M: Lymphocyte infiltration and
prognosis in colorectal cancer. Lancet Oncol. 10:840–841. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Balkwill F and Mantovani A: Inflammation
and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu H, Ubukata H, Tabuchi T, et al: It is
possible that tumour-infiltrating granulocytes promote tumour
progression. Oncol Rep. 22:29–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tan KW, Chong SZ, Wong FH, Evrard M, Tan
SM, Keeble J, Kemeny DM, Ng LG, Abastado JP and Angeli V:
Neutrophils contribute to inflammatory lymphangiogenesis by
increasing VEGF-A bioavailability and secreting VEGF-D. Blood.
122:3666–3677. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen L, Li Q, Zhou XD, Shi Y, Yang L, Xu
SL, Chen C, Cui YH, Zhang X and Bian XW: Increased pro-angiogenic
factors, infiltrating neutrophils and CD163(+) macrophages in
bronchoalveolar lavage fluid from lung cancer patients. Int
Immunopharmacol. 20:74–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Geraghty P, Rogan MP, Greene CM, Boxio RM,
Poiriert T, O'Mahony M, Belaaouaj A, O'Neill SJ, Taggart CC and
McElvaney NG: Neutrophil elastase up-regulates cathepsin B and
matrix metalloprotease-2 expression. J Immunol. 178:5871–5878.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Scapini P, Nesi L, Morini M, Tanghetti E,
Belleri M, Noonan D, Presta M, Albini A and Cassatella MA:
Generation of biologically active angiostatin kringle 1–3 by
activated human neutrophils. J Immunol. 168:5798–5804. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kay HD and Smith DL: Regulation of human
lymphocyte-mediated natural killer (NK) cell activity. I.
Inhibition in vitro by peripheral blood granulocytes. J
Immunol. 130:475–483. 1983.PubMed/NCBI
|
|
34
|
Ietomi K: A study on the role of
granulocytes in carcinomabearing hosts-G/L ratio as a new host
indicator. Nippon Gan Chiryo Gakkai Shi. 25:662–671. 1990.(In
Japanese). PubMed/NCBI
|
